Title:
NOVEL CATIONIC LIPID COMPOUND
Document Type and Number:
WIPO Patent Application WO/2023/029599
Kind Code:
A1
Abstract:
The present invention relates to a lipid compound. The lipid compound can be used alone, or can be used in combination with other lipid components such as neutral lipids, spotted lipids, steroids and/or analogs thereof, and/or polymer-conjugated lipids, so as to form a lipid nanoparticle for delivering a therapeutic agent and/or a prophylactic agent.
More Like This:
| JP2003522739 | [Title of Invention] Selective Neurokinin Antagonist |
| JPS62129259 | ETHANOLAMINE DERIVATIVE |
Inventors:
HUANG CAIGU (CN)
TAN JUNRONG (CN)
HUANG TIEQIANG (CN)
TAN JUNRONG (CN)
HUANG TIEQIANG (CN)
Application Number:
PCT/CN2022/093716
Publication Date:
March 09, 2023
Filing Date:
May 19, 2022
Export Citation:
Assignee:
GUANGZHOU ANOVENT PHARMACEUTICAL CO LTD (CN)
International Classes:
C07C217/46; A61K9/127; C07D317/24
Foreign References:
| CN101163796A | 2008-04-16 | |||
| CN102245590A | 2011-11-16 | |||
| CN112979483A | 2021-06-18 | |||
| CN102905763A | 2013-01-30 |
Download PDF: